Jubilant Pharmova Limited — Others, 18-05-2025: Copy of Newspaper Publication

Jubilant Pharmova has announced a board meeting to approve the financial results for the quarter and half-year ended March 31, 2025. The company has provided access details to the complete audited standalone and consolidated results, allowing investors to review its latest performance. This update enhances transparency and keeps shareholders informed about the company’s financial and operational status.